PKA/AMPK signaling in relation to adiponectin’s antiproliferative effect on multiple myeloma cells (original) (raw)
Blair CK, Cerhan JR, Folsom AR, Ross JA . Anthropometric characteristics and risk of multiple myeloma. Epidemiology 2005; 16: 691–694. ArticlePubMed Google Scholar
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569–578. ArticlePubMed Google Scholar
Britton JA, Khan AE, Rohrmann S, Becker N, Linseisen J, Nieters A et al. Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica 2008; 93: 1666–1677. ArticlePubMed Google Scholar
Sprynski AC, Hose D, Caillot L, Reme T, Shaughnessy JD Jr, Barlogie B et al. The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor. Blood 2009; 113: 4614–4626. ArticleCASPubMed Google Scholar
Swarbrick MM, Havel PJ . Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 2008; 6: 87–102. ArticleCASPubMedPubMed Central Google Scholar
Piya MK, McTernan PG, Kumar S . Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. J Endocrinol 2013; 216: T1–T15. ArticleCASPubMed Google Scholar
Yamauchi T, Kadowaki T . Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab 2013; 17: 185–196. ArticleCASPubMed Google Scholar
Dalamaga M, Diakopoulos KN, Mantzoros CS . The role of adiponectin in cancer: a review of current evidence. Endocr Rev 2012; 33: 547–594. ArticleCASPubMedPubMed Central Google Scholar
Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004; 101: 2476–2481. ArticleCASPubMedPubMed Central Google Scholar
Hofmann JN, Liao LM, Pollak MN, Wang Y, Pfeiffer RM, Baris D et al. A prospective study of circulating adipokine levels and risk of multiple myeloma. Blood 2012; 120: 4418–4420. ArticleCASPubMedPubMed Central Google Scholar
Fowler JA, Lwin ST, Drake MT, Edwards JR, Kyle RA, Mundy GR et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood 2011; 118: 5872–5882. ArticleCASPubMedPubMed Central Google Scholar
Deepa SS, Dong LQ . APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab 2009; 296: E22–E36. ArticleCASPubMed Google Scholar
Mihaylova MM, Shaw RJ . The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011; 13: 1016–1023. ArticleCASPubMedPubMed Central Google Scholar
Mason P, Liang B, Li L, Fremgen T, Murphy E, Quinn A et al. SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One 2012; 7: e33823. ArticleCASPubMedPubMed Central Google Scholar
Steinbrunn T, Stuhmer T, Gattenlohner S, Rosenwald A, Mottok A, Unzicker C et al. Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival. Blood 2011; 117: 1998–2004. ArticleCASPubMed Google Scholar
Hardie DG, Carling D . The AMP-activated protein kinase–fuel gauge of the mammalian cell? Eur J Biochem 1997; 246: 259–273. ArticleCASPubMed Google Scholar
Owen MR, Doran E, Halestrap AP . Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000; 348 (Pt 3): 607–614. ArticleCASPubMedPubMed Central Google Scholar
Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167–1174. ArticleCASPubMedPubMed Central Google Scholar
Insel PA, Zhang L, Murray F, Yokouchi H, Zambon AC . Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger. Acta Physiol (Oxf) 2012; 204: 277–287. ArticleCAS Google Scholar
Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ . Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res 2008; 78: 376–384. ArticleCASPubMed Google Scholar
Park PH, Huang H, McMullen MR, Bryan K, Nagy LE . Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in RAW 264.7 macrophages. J Leukoc Biol 2008; 83: 1258–1266. ArticleCASPubMed Google Scholar
Li G, Cong L, Gasser J, Zhao J, Chen K, Li F . Mechanisms underlying the anti-proliferative actions of adiponectin in human breast cancer cells, MCF7-dependency on the cAMP/protein kinase-A pathway. Nutr Cancer 2011; 63: 80–88. ArticleCASPubMed Google Scholar
Wijesekara N, Krishnamurthy M, Bhattacharjee A, Suhail A, Sweeney G, Wheeler MB . Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J Biol Chem 2010; 285: 33623–33631. ArticleCASPubMedPubMed Central Google Scholar
Kim KY, Baek A, Hwang JE, Choi YA, Jeong J, Lee MS et al. Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation. Cancer Res 2009; 69: 4018–4026. ArticleCASPubMed Google Scholar
Hutchinson DS, Chernogubova E, Dallner OS, Cannon B, Bengtsson T . Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 2005; 48: 2386–2395. ArticleCASPubMed Google Scholar
Lou L, Urbani J, Ribeiro-Neto F, Altschuler DL . cAMP inhibition of Akt is mediated by activated and phosphorylated Rap1b. J Biol Chem 2002; 277: 32799–32806. ArticleCASPubMed Google Scholar
Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990; 265: 5267–5272. CASPubMed Google Scholar
Bhatt AP, Jacobs SR, Freemerman AJ, Makowski L, Rathmell JC, Dittmer DP et al. Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci USA 2012; 109: 11818–11823. ArticleCASPubMedPubMed Central Google Scholar
Menendez JA, Lupu R . Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763–777. ArticleCASPubMed Google Scholar
Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, Brusselmans K et al. Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res 2007; 67: 8180–8187. ArticleCASPubMed Google Scholar
Swinnen JV, Brusselmans K, Verhoeven G . Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006; 9: 358–365. ArticleCASPubMed Google Scholar
Ha J, Daniel S, Broyles SS, Kim KH . Critical phosphorylation sites for acetyl-CoA carboxylase activity. J Biol Chem 1994; 269: 22162–22168. CASPubMed Google Scholar
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288–1295. ArticleCASPubMed Google Scholar
Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH et al. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol 2010; 24: 1441–1452. ArticleCASPubMedPubMed Central Google Scholar
Halvorson DL, McCune SA . Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoic acid. Lipids 1984; 19: 851–856. ArticleCASPubMed Google Scholar
McCune SA, Harris RA . Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis. J Biol Chem 1979; 254: 10095–10101. CASPubMed Google Scholar
Okada-Iwabu M, Yamauchi T, Iwabu M, Honma T, Hamagami K, Matsuda K et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 2013; 503: 493–499. ArticleCASPubMed Google Scholar
Schmitt JM, Stork PJ . PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1. Mol Cell 2002; 9: 85–94. ArticleCASPubMed Google Scholar
Naviglio S, Di Gesto D, Illiano F, Chiosi E, Giordano A, Illiano G et al. Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells. J Cell Physiol 2010; 225: 801–809. ArticleCASPubMed Google Scholar
Collins SP, Reoma JL, Gamm DM, Uhler MD . LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem J 2000; 345 (Pt 3): 673–680. ArticleCASPubMedPubMed Central Google Scholar
Xie Z, Dong Y, Scholz R, Neumann D, Zou MH . Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells. Circulation 2008; 117: 952–962. ArticleCASPubMedPubMed Central Google Scholar
Fu D, Wakabayashi Y, Lippincott-Schwartz J, Arias IM . Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway. Proc Natl Acad Sci USA 2011; 108: 1403–1408. ArticleCASPubMedPubMed Central Google Scholar
Mashima T, Seimiya H, Tsuruo T . De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer 2009; 100: 1369–1372. ArticleCASPubMedPubMed Central Google Scholar
Lane MD, Moss J, Polakis SE . Acetyl coenzyme A carboxylase. Curr Top Cell Regul 1974; 8: 139–195. ArticleCASPubMed Google Scholar
Pape ME, Lopez-Casillas F, Kim KH . Physiological regulation of acetyl-CoA carboxylase gene expression: effects of diet, diabetes, and lactation on acetyl-CoA carboxylase mRNA. Arch Biochem Biophys 1988; 267: 104–109. ArticleCASPubMed Google Scholar
Tirado-Velez JM, Joumady I, Saez-Benito A, Cozar-Castellano I, Perdomo G . Inhibition of fatty acid metabolism reduces human myeloma cells proliferation. PLoS One 2012; 7: e46484. ArticleCASPubMedPubMed Central Google Scholar
Guo D, Hildebrandt IJ, Prins RM, Soto H, Mazzotta MM, Dang J et al. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proc Natl Acad Sci USA 2009; 106: 12932–12937. ArticleCASPubMedPubMed Central Google Scholar
Lin VC, Tsai YC, Lin JN, Fan LL, Pan MH, Ho CT et al. Activation of AMPK by pterostilbene suppresses lipogenesis and cell-cycle progression in p53 positive and negative human prostate cancer cells. J Agric Food Chem 2012; 60: 6399–6407. ArticleCASPubMed Google Scholar
Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P et al. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 2000; 20: 6704–6711. ArticleCASPubMedPubMed Central Google Scholar
Horton JD, Goldstein JL, Brown MS . SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109: 1125–1131. ArticleCASPubMedPubMed Central Google Scholar
Zhao S, Zhu L, Duan H, Liu S, Liu Q, Liu W et al. PI3K/Akt pathway mediates high glucose-induced lipid accumulation in human renal proximal tubular cells via spliced XBP-1. J Cell Biochem 2012; 113: 3288–3298. ArticleCASPubMed Google Scholar
Porstmann T, Griffiths B, Chung YL, Delpuech O, Griffiths JR, Downward J et al. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 2005; 24: 6465–6481. ArticleCASPubMed Google Scholar